Results 221 to 230 of about 2,131,498 (303)

Redefining social medicine from Latin America: Historical foundations and contemporary directions. [PDF]

PLOS Glob Public Health
Ortega F, Abarca-Brown G.
europepmc   +1 more source

Delineating gender/sex‐related studies through bibliometric analysis

Journal of the Association for Information Science and Technology, EarlyView.
Abstract The multidisciplinary and socially grounded nature of Women's/Gender/Feminist Studies poses unique challenges for bibliometric analysis, as it extends beyond conventional disciplinary boundaries. This paper makes three key contributions: (1) We propose a novel retrieval method for constructing a corpus of scholarly documents in research areas ...
Natsumi S. Shokida, Diego Kozlowski, Vincent Larivière   +2 more
wiley   +1 more source

Estimating mortality in conflict settings: expert perspectives on methods, barriers, and ethical challenges. [PDF]

BMC Public Health
Maddah D, Robertson T, Hanson I, Diwan RA, Gray N, Attia Y, Vadi R.   +6 more
europepmc   +1 more source

Why We Need to Study Assisted Methods to Teach Typing to Nonspeaking Autistic People

Autism Research, EarlyView.
ABSTRACT At least one third of autistic people have limited or no speech. Most nonspeaking autistic people are never provided alternatives that would enable the full range of expression that speech allows, significantly limiting their access to educational, social, and employment opportunities.
Vikram K. Jaswal, Barry M. Prizant, Morgan D. Barense, Kristie Patten, Gary Stobbe   +4 more
wiley   +1 more source

From governance scores to governance impact: Closing the know-do gap in AMR policy evaluation. [PDF]

One Health
Zhang XX, Zhu YZ, Zhou XN.
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Redefining water scarcity through the integrated water strategic resilience index amid climate and conflict pressures. [PDF]

Sci Rep
Verre F, Kumar K, Berndtsson R, Hashemi H.   +3 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

The politics of integrating health systems and public programs: a review of political headwinds, tailwinds, and policy maker recommendations. [PDF]

Eur J Public Health
Kavanagh NM, Menon A, McIntyre A.
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source